Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ruud Dings

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
25
2022
184
3.870
Why?
Proteins
17
2010
353
2.310
Why?
Neovascularization, Pathologic
17
2022
158
2.300
Why?
Calixarenes
7
2017
9
1.850
Why?
Melanoma, Experimental
6
2021
34
1.760
Why?
Galectin 1
8
2024
20
1.730
Why?
Antineoplastic Agents
14
2024
1217
1.490
Why?
Peptides
20
2017
236
1.290
Why?
Mice
47
2024
5936
1.220
Why?
Neoplasms
14
2024
1302
1.140
Why?
Animals
53
2024
13455
1.000
Why?
Endothelial Cells
10
2022
283
0.980
Why?
Lung Neoplasms
5
2024
631
0.980
Why?
Gold
7
2023
85
0.860
Why?
Ovarian Neoplasms
8
2008
460
0.830
Why?
Oxygen
6
2020
333
0.810
Why?
Cell Line, Tumor
18
2024
1423
0.770
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
168
0.740
Why?
Carcinoma, Squamous Cell
4
2019
330
0.720
Why?
Proto-Oncogene Proteins c-met
1
2021
19
0.700
Why?
Peptide Fragments
5
2013
208
0.690
Why?
Mammary Neoplasms, Experimental
6
2015
122
0.680
Why?
Radiation-Sensitizing Agents
4
2023
51
0.670
Why?
Head and Neck Neoplasms
3
2019
286
0.650
Why?
Carcinoma, Lewis Lung
1
2019
10
0.640
Why?
Molecular Targeted Therapy
2
2018
133
0.610
Why?
Preservation, Biological
1
2018
9
0.610
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
78
0.600
Why?
Radiation Tolerance
5
2020
78
0.600
Why?
Protein Kinase Inhibitors
1
2021
226
0.600
Why?
CD8-Positive T-Lymphocytes
1
2019
131
0.590
Why?
Anti-Bacterial Agents
4
2019
802
0.590
Why?
Galectins
1
2018
7
0.570
Why?
Metal Nanoparticles
4
2023
66
0.550
Why?
Hyperthermia, Induced
3
2019
114
0.530
Why?
Bacteria
1
2018
220
0.530
Why?
Mice, Nude
12
2019
231
0.520
Why?
Radiotherapy
5
2021
128
0.510
Why?
Xenograft Model Antitumor Assays
11
2020
217
0.490
Why?
Pseudomonas aeruginosa
2
2013
77
0.460
Why?
Combined Modality Therapy
11
2020
638
0.410
Why?
Benzofurans
2
2012
18
0.410
Why?
Cytotoxins
1
2013
15
0.400
Why?
Cell Proliferation
10
2024
1024
0.400
Why?
Drug Design
4
2014
121
0.390
Why?
Oxidation-Reduction
3
2024
327
0.390
Why?
Pseudomonas Infections
1
2013
54
0.390
Why?
Endothelium, Vascular
8
2010
257
0.380
Why?
Carbohydrate Metabolism
1
2012
25
0.380
Why?
Humans
44
2024
52469
0.380
Why?
Nanostructures
3
2023
42
0.380
Why?
Neoplasms, Experimental
4
2020
112
0.370
Why?
Benzeneacetamides
2
2024
12
0.370
Why?
Glutaminase
2
2024
18
0.370
Why?
Bacteremia
1
2013
90
0.370
Why?
Sesquiterpenes
3
2010
92
0.360
Why?
Angiostatic Proteins
1
2011
1
0.350
Why?
Immunity, Cellular
1
2011
64
0.340
Why?
Cell Survival
8
2024
600
0.340
Why?
Molecular Mimicry
2
2007
35
0.340
Why?
Dendritic Cells
3
2021
136
0.330
Why?
Endothelium
4
2022
38
0.330
Why?
Carboplatin
3
2024
56
0.320
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
1025
0.320
Why?
Tumor Necrosis Factor-alpha
4
2019
395
0.310
Why?
Immunotherapy, Adoptive
1
2011
167
0.300
Why?
Apoptosis
7
2024
1121
0.300
Why?
Cells, Cultured
8
2013
1586
0.300
Why?
Vascular Endothelial Growth Factor A
7
2022
187
0.300
Why?
Intercellular Adhesion Molecule-1
5
2022
59
0.300
Why?
T-Lymphocytes
1
2011
327
0.290
Why?
Structure-Activity Relationship
6
2012
405
0.290
Why?
Polyethylene Glycols
3
2021
91
0.290
Why?
Mice, Inbred C57BL
8
2021
1897
0.290
Why?
Phototherapy
2
2019
26
0.290
Why?
Tumor Cells, Cultured
6
2019
447
0.280
Why?
Amino Acid Sequence
5
2012
571
0.280
Why?
Female
24
2020
28191
0.270
Why?
Drug Resistance, Neoplasm
2
2024
327
0.260
Why?
Magnetic Resonance Spectroscopy
5
2012
253
0.260
Why?
Blood Vessels
4
2015
72
0.250
Why?
Antibodies, Monoclonal
2
2007
478
0.250
Why?
Molecular Sequence Data
5
2012
770
0.240
Why?
Disease Models, Animal
7
2020
1480
0.240
Why?
Nanoparticles
2
2017
127
0.230
Why?
Cell Division
7
2010
290
0.220
Why?
Bystander Effect
1
2024
25
0.220
Why?
Cysteine
1
2024
50
0.220
Why?
Human Umbilical Vein Endothelial Cells
3
2014
102
0.220
Why?
Buthionine Sulfoximine
1
2024
13
0.220
Why?
Nanotubes
2
2021
17
0.210
Why?
Models, Molecular
4
2024
352
0.210
Why?
Thiadiazoles
2
2024
18
0.210
Why?
Flow Cytometry
2
2017
400
0.210
Why?
Cisplatin
1
2024
284
0.190
Why?
Alanine
3
2012
43
0.190
Why?
Protein Binding
3
2012
670
0.180
Why?
Carcinoma, Renal Cell
1
2022
112
0.180
Why?
Binding Sites
2
2012
376
0.180
Why?
Optical Imaging
2
2020
25
0.180
Why?
Silver
2
2021
47
0.180
Why?
Polyurethanes
1
2021
10
0.170
Why?
Kidney Neoplasms
1
2022
182
0.170
Why?
Radiation
1
2020
14
0.170
Why?
Materials Testing
1
2021
55
0.170
Why?
Forkhead Transcription Factors
1
2021
119
0.170
Why?
Spectrum Analysis
1
2020
54
0.170
Why?
Biocompatible Materials
1
2021
65
0.170
Why?
Mice, Inbred BALB C
5
2020
310
0.160
Why?
CD4-Positive T-Lymphocytes
1
2021
165
0.160
Why?
Neoplasm Transplantation
5
2007
86
0.160
Why?
Mice, Knockout
3
2012
909
0.160
Why?
Disease Progression
3
2019
872
0.160
Why?
Oxygen Consumption
1
2020
199
0.160
Why?
Lactose
2
2024
8
0.160
Why?
Spectrum Analysis, Raman
1
2019
42
0.150
Why?
Immunotherapy
1
2020
243
0.150
Why?
Specimen Handling
1
2018
56
0.150
Why?
Biological Assay
1
2018
47
0.150
Why?
Drug Delivery Systems
2
2019
147
0.150
Why?
Time Factors
6
2017
2989
0.150
Why?
Indazoles
1
2018
47
0.140
Why?
Carbohydrates
1
2018
41
0.140
Why?
Feces
1
2018
154
0.140
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
62
0.140
Why?
Temperature
1
2018
165
0.140
Why?
Cell Hypoxia
4
2015
83
0.140
Why?
Histocompatibility Antigens Class II
1
2017
34
0.140
Why?
Neoplastic Cells, Circulating
1
2017
34
0.140
Why?
Tumor Microenvironment
1
2019
252
0.130
Why?
Drug Therapy, Combination
1
2018
399
0.130
Why?
Male
9
2019
26793
0.130
Why?
Epithelial Cells
1
2018
214
0.130
Why?
Cell Line
4
2017
1030
0.130
Why?
Lipopolysaccharides
2
2008
205
0.130
Why?
Umbilical Veins
4
2010
21
0.120
Why?
Enzyme Inhibitors
1
2018
371
0.120
Why?
Molecular Imaging
1
2015
28
0.120
Why?
Leukocytes
3
2006
60
0.120
Why?
Azides
1
2014
9
0.110
Why?
Tumor Burden
2
2013
133
0.110
Why?
Fluorine Radioisotopes
1
2014
25
0.110
Why?
Cell Transformation, Neoplastic
2
2007
184
0.110
Why?
Immunohistochemistry
5
2020
980
0.110
Why?
Interleukin-2
2
2021
69
0.110
Why?
Drug Synergism
2
2005
148
0.110
Why?
Cell Adhesion
3
2006
164
0.110
Why?
Piperacillin
1
2013
24
0.100
Why?
Peptidomimetics
1
2012
2
0.100
Why?
Penicillanic Acid
1
2013
21
0.100
Why?
Agglutination Tests
1
2012
5
0.100
Why?
Allosteric Regulation
1
2012
16
0.100
Why?
Inflammation Mediators
1
2013
116
0.100
Why?
Cell Cycle
1
2013
238
0.090
Why?
Antimicrobial Cationic Peptides
2
2008
30
0.090
Why?
Neoplastic Stem Cells
1
2012
90
0.090
Why?
Up-Regulation
2
2011
462
0.090
Why?
Partial Pressure
1
2011
14
0.090
Why?
Metformin
1
2012
81
0.090
Why?
Glutamine
2
2024
176
0.090
Why?
Adjuvants, Immunologic
1
2011
52
0.090
Why?
Fibroblasts
1
2013
359
0.090
Why?
Chemotherapy, Adjuvant
1
2011
122
0.080
Why?
Cell Movement
4
2006
273
0.080
Why?
Spiro Compounds
1
2010
8
0.080
Why?
Cytokines
1
2013
624
0.080
Why?
Lignans
1
2008
7
0.070
Why?
Salmonella typhimurium
1
2008
42
0.070
Why?
Klebsiella pneumoniae
1
2008
20
0.070
Why?
Amino Acid Substitution
1
2008
79
0.070
Why?
Furans
1
2008
30
0.070
Why?
Surface Properties
1
2007
62
0.070
Why?
Escherichia coli
1
2008
186
0.070
Why?
Angiostatins
2
2006
2
0.070
Why?
Endotoxins
1
2006
22
0.070
Why?
Vascular Neoplasms
1
2007
17
0.070
Why?
Concept Formation
1
2006
12
0.060
Why?
Gram-Negative Bacteria
1
2006
34
0.060
Why?
Protein Structure, Secondary
2
2003
71
0.060
Why?
Interleukin-8
1
2006
86
0.060
Why?
Genes, Synthetic
1
2005
1
0.060
Why?
Protein Engineering
1
2005
18
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2007
235
0.060
Why?
Cloning, Molecular
1
2005
181
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
147
0.060
Why?
Angiogenic Proteins
1
2004
5
0.060
Why?
Colonic Neoplasms
1
2006
163
0.060
Why?
Dietary Supplements
1
2008
464
0.060
Why?
Protein Unfolding
1
2024
7
0.060
Why?
Histones
1
2006
316
0.060
Why?
Feasibility Studies
1
2006
403
0.060
Why?
Disulfides
1
2024
17
0.060
Why?
Diphtheria Toxin
1
2004
4
0.060
Why?
Mutagenesis, Site-Directed
1
2024
97
0.050
Why?
Protein Folding
1
2024
61
0.050
Why?
Mammary Neoplasms, Animal
1
2004
33
0.050
Why?
Osmosis
1
2003
5
0.050
Why?
Infusion Pumps
1
2003
12
0.050
Why?
Circular Dichroism
1
2003
42
0.050
Why?
Dose-Response Relationship, Drug
2
2004
1372
0.050
Why?
Plasminogen
1
2003
3
0.050
Why?
Serum Albumin
1
2003
58
0.050
Why?
Extracellular Matrix
1
2003
112
0.050
Why?
Immune Tolerance
1
2022
91
0.050
Why?
Gene Expression Regulation, Neoplastic
4
2008
853
0.050
Why?
Reactive Oxygen Species
1
2024
422
0.050
Why?
Endostatins
3
2007
4
0.050
Why?
Neoplasm Invasiveness
1
2022
277
0.050
Why?
Immune System
1
2021
41
0.040
Why?
Immunity
1
2021
40
0.040
Why?
Melanoma
1
2004
278
0.040
Why?
Ethers
1
2021
8
0.040
Why?
Regenerative Medicine
1
2021
12
0.040
Why?
Tissue Scaffolds
1
2021
40
0.040
Why?
Angiogenesis Inducing Agents
1
2000
7
0.040
Why?
Dose-Response Relationship, Radiation
1
2020
183
0.040
Why?
Tissue Engineering
1
2021
74
0.040
Why?
Bone Marrow Cells
1
2021
190
0.040
Why?
Adenocarcinoma
1
2004
402
0.040
Why?
Mice, Inbred C3H
2
2012
81
0.040
Why?
Gene Expression Profiling
1
2004
1108
0.040
Why?
Skin Neoplasms
1
2004
500
0.040
Why?
Flavin-Adenine Dinucleotide
1
2018
4
0.040
Why?
NAD
1
2018
45
0.040
Why?
Inflammation
1
2022
643
0.040
Why?
Microcirculation
2
2010
63
0.040
Why?
Guidelines as Topic
1
2018
110
0.030
Why?
Microscopy, Fluorescence
1
2018
147
0.030
Why?
Glutathione
1
2019
305
0.030
Why?
Phagocytosis
1
2017
54
0.030
Why?
Glycolysis
1
2017
73
0.030
Why?
Transplantation, Heterologous
2
2008
78
0.030
Why?
Clonal Anergy
2
2006
13
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Nitroimidazoles
1
2015
16
0.030
Why?
Microbubbles
1
2015
26
0.030
Why?
Cell Count
1
2015
144
0.030
Why?
Stromal Cells
1
2015
77
0.030
Why?
Pressure
1
2015
103
0.030
Why?
Down-Regulation
2
2006
344
0.030
Why?
Paclitaxel
2
2006
89
0.030
Why?
Drug Evaluation, Preclinical
1
2015
142
0.030
Why?
Cycloaddition Reaction
1
2014
1
0.030
Why?
Radiochemistry
1
2014
2
0.030
Why?
Click Chemistry
1
2014
3
0.030
Why?
Random Allocation
1
2015
285
0.030
Why?
Radiotherapy Dosage
1
2015
253
0.030
Why?
Recombinant Proteins
2
2006
495
0.030
Why?
Imaging, Three-Dimensional
1
2015
151
0.030
Why?
Cell Differentiation
1
2017
673
0.030
Why?
Contrast Media
1
2015
173
0.030
Why?
Molecular Structure
1
2014
315
0.030
Why?
Ultrasonography
1
2015
423
0.030
Why?
Chromatography, High Pressure Liquid
1
2014
335
0.030
Why?
Ribosomal Protein S6 Kinases
1
2012
8
0.020
Why?
Adenylate Kinase
1
2012
10
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
82
0.020
Why?
Rats
2
2008
3180
0.020
Why?
Radiometry
1
2012
127
0.020
Why?
4-Butyrolactone
1
2008
5
0.020
Why?
Butylene Glycols
1
2008
14
0.020
Why?
Phytoestrogens
1
2008
23
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
50
0.020
Why?
Ovariectomy
1
2008
113
0.020
Why?
Receptors, Progesterone
1
2008
66
0.020
Why?
Estrogen Receptor beta
1
2008
54
0.020
Why?
Estrogen Receptor alpha
1
2008
85
0.020
Why?
Carcinogens
1
2008
193
0.020
Why?
Cell Growth Processes
1
2007
24
0.020
Why?
Horseshoe Crabs
1
2006
3
0.020
Why?
Blood Bactericidal Activity
1
2006
4
0.020
Why?
Lipid A
1
2006
4
0.020
Why?
Polymyxin B
1
2006
4
0.020
Why?
Neutralization Tests
1
2006
26
0.020
Why?
Cytidine
1
2006
5
0.020
Why?
Pyrroles
1
2007
72
0.020
Why?
DNA Modification Methylases
1
2006
28
0.020
Why?
Endotoxemia
1
2006
35
0.020
Why?
Acetylation
1
2006
96
0.020
Why?
Methylation
1
2006
126
0.020
Why?
Vimentin
1
2006
32
0.020
Why?
Chick Embryo
1
2006
81
0.020
Why?
Blood Proteins
1
2006
84
0.020
Why?
Gene Silencing
1
2006
120
0.020
Why?
Nucleic Acid Hybridization
1
2006
55
0.020
Why?
Cyclohexanes
1
2006
4
0.020
Why?
Transfection
1
2007
369
0.020
Why?
Histone Deacetylase Inhibitors
1
2006
57
0.020
Why?
Zebrafish
1
2006
60
0.020
Why?
Histone Deacetylases
1
2006
51
0.020
Why?
Vascular Cell Adhesion Molecule-1
1
2006
38
0.020
Why?
Pichia
1
2005
8
0.020
Why?
Gene Transfer Techniques
1
2005
44
0.010
Why?
Cyclophosphamide
1
2006
172
0.010
Why?
Neovascularization, Physiologic
1
2005
87
0.010
Why?
Sequence Homology, Nucleic Acid
1
2004
48
0.010
Why?
Membrane Proteins
1
2006
336
0.010
Why?
Indoles
1
2007
276
0.010
Why?
Treatment Outcome
1
2014
5470
0.010
Why?
Necrosis
1
2004
170
0.010
Why?
Skin
1
2007
420
0.010
Why?
Antibodies
1
2004
150
0.010
Why?
In Situ Nick-End Labeling
1
2003
54
0.010
Why?
Base Sequence
1
2004
634
0.010
Why?
Sequence Homology, Amino Acid
1
2003
137
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
582
0.010
Why?
Epigenesis, Genetic
1
2006
403
0.010
Why?
Mice, Transgenic
1
2004
563
0.010
Why?
RNA, Messenger
1
2004
1139
0.010
Why?
Endothelial Growth Factors
1
2000
11
0.010
Why?
Vascular Endothelial Growth Factors
1
2000
15
0.010
Why?
Fibroblast Growth Factor 2
1
2000
35
0.010
Why?
Lymphokines
1
2000
20
0.010
Why?
Scrotum
1
2000
31
0.010
Why?
Interleukin-1
1
2000
105
0.010
Why?
Models, Biological
1
2002
739
0.010
Why?
Breast Neoplasms
1
2004
1203
0.010
Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description